ICD-10 Coding for Testosterone Deficiency(E23.0, E23.0B, E23.0H)
Explore ICD-10 coding for testosterone deficiency, including primary, secondary, and postprocedural hypogonadism. Learn documentation requirements and coding pitfalls.
Complete code families applicable to Testosterone Deficiency
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E29.1 | Testicular hypofunction | Use for primary hypogonadism with confirmed low testosterone and elevated gonadotropins. |
|
| E23.0 | Hypopituitarism | Use for secondary hypogonadism with pituitary origin. |
|
| E89.5 | Postprocedural testicular hypofunction | Use for hypogonadism resulting from surgical procedures. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutTestosterone Deficiency
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Testosterone Deficiency.
Documenting 'low testosterone' without lab results
Impact
Clinical: Inadequate basis for diagnosis., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Always include lab results in documentation., Verify that tests meet clinical guidelines.
Using E29.1 for post-surgical hypogonadism
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use E89.5 for postprocedural cases with documentation of the procedure.
Failure to document two testosterone tests
Impact
Reimbursement: Claims may be denied due to insufficient documentation., Compliance: Non-compliance with clinical guidelines., Data Quality: Incomplete clinical data.
Mitigation
Ensure documentation includes two separate morning testosterone levels.
Testosterone Therapy Documentation
Impact
Inadequate documentation of ongoing therapy.
Mitigation
Regularly update patient records with therapy details.